Literature DB >> 17176301

Guidelines for clinical trials in melasma. Pigmentation Disorders Academy.

A Pandya1, M Berneburg, J-P Ortonne, M Picardo.   

Abstract

There have been very few well-conducted trials in melasma and this makes the process of comparing treatment outcome between trials difficult. The Pigmentary Disorders Academy has examined the issues relating to clinical trials on melasma, and has proposed recommendations on how they should be conducted. This covers all aspects including correct diagnosis of the condition, evaluation of efficacy and safety outcome, and overall clinical trial design. It is anticipated that the establishment of accepted guidelines on the conduct of clinical trials in melasma will greatly assist the dermatological community.

Entities:  

Mesh:

Year:  2006        PMID: 17176301     DOI: 10.1111/j.1365-2133.2006.07590.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  Evaluating Oral Glutathione Plus Ascorbic Acid, Alpha-lipoic Acid, and Zinc Aspartate as a Skin-lightening Agent: An Indonesian Multicenter, Randomized, Controlled Trial.

Authors:  Irma Bernadette S Sitohang; Anis Irawan Anwar; Nelva K Jusuf; Abraham Arimuko; Lilik Norawati; Silvia Veronica
Journal:  J Clin Aesthet Dermatol       Date:  2021-07-01

2.  A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma.

Authors:  Josefina Navarrete-Solís; Juan Pablo Castanedo-Cázares; Bertha Torres-Álvarez; Cuauhtemoc Oros-Ovalle; Cornelia Fuentes-Ahumada; Francisco Javier González; Juan David Martínez-Ramírez; Benjamin Moncada
Journal:  Dermatol Res Pract       Date:  2011-07-21

Review 3.  Melasma: a clinical and epidemiological review.

Authors:  Ana Carolina Handel; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

4.  Reduction of facial pigmentation of melasma by topical lignin peroxidase: A novel fast-acting skin-lightening agent.

Authors:  Shao-Min Zhong; Nan Sun; Hui-Xian Liu; Yue-Qing Niu; Yan Wu
Journal:  Exp Ther Med       Date:  2014-12-08       Impact factor: 2.447

5.  Effect of 82% Lactic Acid in Treatment of Melasma.

Authors:  Rashmi Singh; Sapna Goyal; Qazi Rais Ahmed; Narendra Gupta; Sujata Singh
Journal:  Int Sch Res Notices       Date:  2014-07-17

6.  Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment.

Authors:  Shymaa Hatem; Seham A Elkheshen; Amany O Kamel; Maha Nasr; Noha H Moftah; Maha H Ragai; Reham S Elezaby; Nada M El Hoffy
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

7.  Lasers for treatment of melasma and post-inflammatory hyperpigmentation.

Authors:  Pooja Arora; Rashmi Sarkar; Vijay K Garg; Latika Arya
Journal:  J Cutan Aesthet Surg       Date:  2012-04

8.  A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian Patients.

Authors:  Charu Bansal; Hira Naik; Hemanta K Kar; Amrita Chauhan
Journal:  J Cutan Aesthet Surg       Date:  2012-10

9.  Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma.

Authors:  Fariba Iraji; Nabet Tagmirriahi; Keyvan Gavidnia
Journal:  Adv Biomed Res       Date:  2012-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.